Fred Hassan has been CEO of three major global pharmaceutical companies and was chairman of Bausch & Lomb until 2013. Hassan has played varying roles at Warburg Pincus, including partner and managing director. Fred also served on the board of Time Warner from 2009 until its sale to AT&T in June 2018. He is presently a board member of Amgen (biotech) and Intrexon (synthetic biology).

Fred graduated with a bachelor’s degree in chemical engineering from Imperial College London. After working in the fertilizer industry with an affiliate of Hercules Inc., he enrolled at Harvard and obtained an MBA in 1972.

Fred was picked by CNBC in January 2014 as one of the world’s top 200 leaders who has had a major influence in the past quarter-century. Fred’s book, Reinvent: A Leader’s Playbook for Serial Success, was published by Wiley in 2013.